{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T04:29:49Z","timestamp":1793593789579,"version":"4.5.0"},"reference-count":71,"publisher":"BMJ","issue":"6","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Med Ethics"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1136\/medethics-2016-103868","type":"journal-article","created":{"date-parts":[[2017,4,14]],"date-time":"2017-04-14T00:40:35Z","timestamp":1492130435000},"page":"391-400","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":16,"title":["From protection to entitlement: selecting research subjects for early phase clinical trials involving breakthrough therapies"],"prefix":"10.1136","volume":"43","author":[{"given":"Nancy S","family":"Jecker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron G","family":"Wightman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abby R","family":"Rosenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas S","family":"Diekema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2017,4,13]]},"reference":[{"key":"key-10.1136\/medethics-2016-103868-1","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1172\/JCI85309","article-title":"CD19 CAR-T cells of defined CD4+:CD8+ composition in adult B cell ALL patients","volume":"126","author":"Turtle","year":"2016","journal-title":"J Clin Inves"},{"key":"key-10.1136\/medethics-2016-103868-2","unstructured":"Keon S . 93 percent of advanced leukemia patients in remission after immunotherapy. Hutch News, 25 April 2016."},{"key":"key-10.1136\/medethics-2016-103868-3"},{"key":"key-10.1136\/medethics-2016-103868-4","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1093\/oso\/9780195113532.003.0009","article-title":"Theories of justice in the context of research","volume-title":"Beyond consent: seeking justice in research","author":"Powers","year":"1998"},{"key":"key-10.1136\/medethics-2016-103868-5","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1093\/oso\/9780195113532.003.0004","article-title":"Children as research subjects","volume-title":"Beyond consent: seeking justice in research","author":"Nelson","year":"1998"},{"key":"key-10.1136\/medethics-2016-103868-6","volume-title":"A history and theory of informed consent","author":"Faden","year":"1986"},{"key":"key-10.1136\/medethics-2016-103868-7","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/oso\/9780195113532.003.0002","article-title":"The evolving story of justice in federal research policy","volume-title":"Beyond consent: seeking justice in research","author":"McCarthy","year":"1998"},{"key":"key-10.1136\/medethics-2016-103868-8","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1177\/1740774507079440","article-title":"Applying justice in clinical trials for diverse populations","volume":"4","author":"Tilburt","year":"2007","journal-title":"Clin Trials"},{"key":"key-10.1136\/medethics-2016-103868-9","unstructured":"U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, Center for Biologics Evaluations and Research. Guidance for Industry: Expedited Programs for Serious Conditions: Drugs and Biologics . 2014. http:\/\/www.fda.gov\/downloads\/drugs\/guidancecomplianceregulatoryinformation\/guidances\/ucm358301.pdf"},{"key":"key-10.1136\/medethics-2016-103868-10","unstructured":"Alexander S . They decide who lives, who dies: medical miracle and a moral burden of a small committee. Life Magazine, November: 102\u2013125. 1962. https:\/\/books.google.com\/books?id=qUoEAAAAMBAJ&lpg=PA1&dq=life+magazine+nov+1962&pg=PA101&hl=en#v=onepage&q&f=false"},{"key":"key-10.1136\/medethics-2016-103868-11","author":"Katz","year":"1967"},{"key":"key-10.1136\/medethics-2016-103868-12","first-page":"357","article-title":"Medical advance and legal lag: hemodialysis and kidney transplantation","volume":"15","author":"Sanders","year":"1968","journal-title":"UCLA Law Rev"},{"key":"key-10.1136\/medethics-2016-103868-13","unstructured":"Macklin R . The ethics of the Ebola outbreak: who should receive experimental treatment? The Doctor's Tablet, Albert Einstein College of Medicine Blog. 2014(a). http:\/\/blogs.einstein.yu.edu\/the-ethics-of-the-ebola-outbreak-who-should-receive-experimental-treatment\/"},{"key":"key-10.1136\/medethics-2016-103868-14","unstructured":"Macklin R . Research Ethics and Ebola. The Doctor's Table, Albert Einstein College of Medicine Blog . 2014(b). http:\/\/blogs.einstein.yu.edu\/research-ethics-and-ebola\/"},{"key":"key-10.1136\/medethics-2016-103868-15","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1056\/NEJMhle1409465","article-title":"Practical, legal, and ethical issues in expanded access to investigational drugs","volume":"372","author":"Darrow","year":"2015","journal-title":"N Engl J Med"},{"key":"key-10.1136\/medethics-2016-103868-16","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1378\/chest.15-0135","article-title":"Ebola virus disease: ethics and emergency medical response","volume":"148","author":"Jecker","year":"2015","journal-title":"CHEST"},{"key":"key-10.1136\/medethics-2016-103868-17","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/S0140-6736(14)61734-7","article-title":"Randomised controlled trials for Ebola: practical and ethical issues","volume":"384","author":"Adebamowo","year":"2014","journal-title":"Lancet"},{"key":"key-10.1136\/medethics-2016-103868-18","unstructured":"World Health Organization. Ethical considerations for use of unregistered interventions for Ebola virus disease (EVD). 2014. http:\/\/www.who.int\/mediacentre\/news\/statements\/2014\/ebola-ethical-review-summary\/en\/Crimp D, 2011. Before occupy. Atlantic, December 6."},{"key":"key-10.1136\/medethics-2016-103868-19","unstructured":"Dunning J , Longuet C , Salam A . Ebola research: an encounter between science and humanitarian action. Humanitarian Alternatives . 2016. http:\/\/alternatives-humanitaires.org\/en\/2016\/01\/11\/ebola-research-an-encounter-between-science-and-humanitarian-action\/"},{"key":"key-10.1136\/medethics-2016-103868-20","unstructured":"Crimp D . Before occupy: how AIDS activists seized control of the FDA in 1988. The Atlantic, 6 December 2011."},{"key":"key-10.1136\/medethics-2016-103868-21","unstructured":"Farber C . Aids and the AZT scandal: SPIN 1989 feature, \u2018Sins of Omission\u2019. SPIN, 5 October 2015."},{"key":"key-10.1136\/medethics-2016-103868-22","unstructured":"Lauritsen J . New York Native, 19 October, 1987."},{"key":"key-10.1136\/medethics-2016-103868-23","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1162\/152651602317533578","article-title":"Exploiting subjects in placebo-controlled trials","volume":"2","author":"Jecker","year":"2002","journal-title":"Am J Bioeth"},{"key":"key-10.1136\/medethics-2016-103868-24","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1056\/NEJM200104053441401","article-title":"Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia","volume":"344","author":"Druker","year":"2001","journal-title":"N Engl J Med"},{"key":"key-10.1136\/medethics-2016-103868-25","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1056\/NEJMoa062867","article-title":"Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia","volume":"355","author":"Druker","year":"2006","journal-title":"N Engl J Med"},{"key":"key-10.1136\/medethics-2016-103868-26","volume-title":"Magic cancer bullet","author":"Vasella","year":"2003"},{"key":"key-10.1136\/medethics-2016-103868-27","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1377\/hlthaff.2015.1145","article-title":"Steady increase in prices for oral anticancer drugs after-market launch suggests a lack of competitive pressure","volume":"35","author":"Bennette","year":"2016","journal-title":"Health Aff (Millwood)"},{"key":"key-10.1136\/medethics-2016-103868-28","unstructured":"Fink S . Drug shortages forcing hard decisions on rationing treatments. New York Times, 29 January 2016."},{"key":"key-10.1136\/medethics-2016-103868-29","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1200\/JCO.2011.41.0936","article-title":"Chemotherapy drug shortages in the United States: genesis and potential solutions","volume":"30","author":"Link","year":"2012","journal-title":"J Clin Oncol"},{"key":"key-10.1136\/medethics-2016-103868-30","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1056\/NEJMp1109772","article-title":"The shortage of essential chemotherapy drugs in the United States","volume":"365","author":"Gatesman","year":"2011","journal-title":"N Engl J Med"},{"key":"key-10.1136\/medethics-2016-103868-31","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1056\/NEJMp1112633","article-title":"Drug shortages\u2014a critical challenge for the generic-drug market","volume":"365","author":"Chabner","year":"2011","journal-title":"N Engl J Med"},{"key":"key-10.1136\/medethics-2016-103868-32","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1056\/NEJMp1212468","article-title":"The Impact of drug shortages on children with cancer\u2014the example of mechlorethamine","volume":"367","author":"Metzger","year":"2012","journal-title":"N Engl J Med"},{"key":"key-10.1136\/medethics-2016-103868-33","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1056\/NEJMc1307379","article-title":"Survey of oncologists about shortages of cancer drugs","volume":"369","author":"Gogineni","year":"2013","journal-title":"N Engl J Med"},{"key":"key-10.1136\/medethics-2016-103868-34","doi-asserted-by":"crossref","first-page":"djv392","DOI":"10.1093\/jnci\/djv392","article-title":"An ethical framework for allocating scarce life-saving chemotherapy and supportive care drugs for childhood cancer","volume":"108","author":"Unguru","year":"2016","journal-title":"J Natl Cancer Inst"},{"key":"key-10.1136\/medethics-2016-103868-35"},{"key":"key-10.1136\/medethics-2016-103868-36","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/oso\/9780195113532.003.0007","article-title":"Convenient and captive populations","volume-title":"Beyond consent: seeking justice in research","author":"Moreno","year":"1998"},{"key":"key-10.1136\/medethics-2016-103868-37","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1136\/bmj.313.7070.1445","article-title":"Informed consent in human experimentation before the Nuremberg code","volume":"313","author":"Vollmann","year":"1996","journal-title":"BMJ"},{"key":"key-10.1136\/medethics-2016-103868-38","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1056\/NEJM196606162742405","article-title":"Ethics and clinical research","volume":"274","author":"Beecher","year":"1966","journal-title":"N Engl J Med"},{"key":"key-10.1136\/medethics-2016-103868-39","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1093\/clinids\/8.1.157","article-title":"The Willowbrook hepatitis studies revisited: ethical aspects","volume":"8","author":"Krugman","year":"1986","journal-title":"Clin Infect Dis"},{"key":"key-10.1136\/medethics-2016-103868-40","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.2105\/AJPH.81.11.1498","article-title":"The Tuskegee Syphilis Study, 1932 to 1972: implications for HIV education and AIDS risk education programs in the black community","volume":"81","author":"Thomas","year":"1991","journal-title":"Am J Pub Health"},{"key":"key-10.1136\/medethics-2016-103868-41","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1001\/jama.1996.03540200053031","article-title":"US Medical Researchers, the Nuremberg Doctors Trial, and the Nuremberg Code: a review of findings of the advisory committee on human radiation experiments","volume":"2276","author":"Faden","year":"1996","journal-title":"JAMA"},{"key":"key-10.1136\/medethics-2016-103868-42","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0140-6736(14)61403-3","article-title":"T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial","volume":"385","author":"Lee","year":"2015","journal-title":"Lancet"},{"key":"key-10.1136\/medethics-2016-103868-43","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1056\/NEJMoa1407222","article-title":"Chimeric antigen receptor T cells for sustained remissions in leukemia","volume":"371","author":"Maude","year":"2014","journal-title":"N Engl J Med"},{"key":"key-10.1136\/medethics-2016-103868-44","doi-asserted-by":"crossref","first-page":"224ra25","DOI":"10.1126\/scitranslmed.3008226","article-title":"Efficacy and toxicity management of 19\u201328z CAR T cell therapy in B cell acute lymphoblastic leukemia","volume":"6","author":"Davilia","year":"2014","journal-title":"Sci Transl Med"},{"issue":"9","key":"key-10.1136\/medethics-2016-103868-45","first-page":"V55","article-title":"The therapeutic misconception: problems and solutions","volume":"40","author":"Lidz","year":"2002","journal-title":"Med Care"},{"key":"key-10.1136\/medethics-2016-103868-46","unstructured":"Pollack A . Juno halts cancer trial using gene-altered cells after 3 deaths. New York Times, 25 July 2016."},{"key":"key-10.1136\/medethics-2016-103868-47","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1136\/medethics-2015-103311","article-title":"Fair subject selection in clinical research: formal equality of opportunity","volume":"42","author":"MacKay","year":"2016","journal-title":"J Med Ethics"},{"key":"key-10.1136\/medethics-2016-103868-48","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1001\/jama.283.20.2701","article-title":"What makes clinical research ethical?","volume":"283","author":"Emanuel","year":"2000","journal-title":"JAMA"},{"key":"key-10.1136\/medethics-2016-103868-49","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s11019-014-9569-6","article-title":"Unequal treatment of human research subjects","volume":"18","author":"Resnick","year":"2015","journal-title":"Med Health Care Philos"},{"key":"key-10.1136\/medethics-2016-103868-50","unstructured":"FDA, Code of Federal Regulation (CFR). Title 21: Food and Drugs, Chapter 1, Subchapter D, Part 312, Subpart 1: \u201cExpanded Access to Investigational Drugs for Treatment Use\u201d. 2015. http:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfcfr\/CFRSearch.cfm?fr=312.305"},{"key":"key-10.1136\/medethics-2016-103868-51","unstructured":"U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, Center for Biologics Evaluations and Research. Expanded Access to Investigation Drugs for Treatment Use: Questions and Answers: Guidance for Industry . 2016. http:\/\/www.fda.gov\/downloads\/drugs\/guidancecomplianceregulatoryinformation\/guidances\/ucm351261.pdf"},{"key":"key-10.1136\/medethics-2016-103868-52","first-page":"211","article-title":"When resources are experimental","volume-title":"Who Lives? Who Dies?","author":"Kilner","year":"1990"},{"key":"key-10.1136\/medethics-2016-103868-53","volume-title":"Who Lives? Who Dies?","author":"Kilner"},{"key":"key-10.1136\/medethics-2016-103868-54","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/COH.0b013e32833ed177","article-title":"What are biomarkers","volume":"5","author":"Strimbu","year":"2010","journal-title":"Curr Opin HIV AIDS"},{"key":"key-10.1136\/medethics-2016-103868-55","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/S0735-1097(86)80302-3","article-title":"Outcome of patients referred for cardiac transplantation","volume":"8","author":"Evans","year":"1986","journal-title":"J Am Coll Cardiol"},{"key":"key-10.1136\/medethics-2016-103868-56","unstructured":"Kilner J . Who Lives? Who Dies? Yale University Press, 1990:125."},{"key":"key-10.1136\/medethics-2016-103868-57","volume-title":"Equality and priority","author":"Parfit","year":"1995"},{"key":"key-10.1136\/medethics-2016-103868-58","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1525\/9780520352797","volume-title":"The abuse of casuistry: a history of moral reasoning","author":"Jonsen","year":"1988"},{"key":"key-10.1136\/medethics-2016-103868-59","doi-asserted-by":"crossref","first-page":"4573","DOI":"10.1200\/JCO.2012.45.2086","article-title":"Recommendations for the return of research results to study participants and guardians: a report from the Children's Oncology Group","volume":"30","author":"Fernandez","year":"2012","journal-title":"J Clin Oncol"},{"key":"key-10.1136\/medethics-2016-103868-60","unstructured":"National Institutes of Health. NIH Policy and Guidelines on the Inclusion of Women and Minorities as Subjects in Clinical Research, amended. 2001. http:\/\/grants.nih.gov\/grants\/funding\/women_min\/guidelines_amended_10_2001.htm"},{"key":"key-10.1136\/medethics-2016-103868-61","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0140-6736(09)60137-9","article-title":"Principles for allocation of scarce medical interventions","volume":"373","author":"Persad","year":"2009","journal-title":"Lancet"},{"key":"key-10.1136\/medethics-2016-103868-62","first-page":"41","article-title":"The misplaced role of urgency in allocation of persistently scarce life-saving organs","volume-title":"Ethical, legal, and social issues in organ transplantation","author":"Brock","year":"2004"},{"key":"key-10.1136\/medethics-2016-103868-63","volume-title":"Morality, mortality, vol. 1: death and whom to save from It","author":"Kamm","year":"1993"},{"key":"key-10.1136\/medethics-2016-103868-64","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0140-6736(05)66518-X","article-title":"Fair process in patient selection for antiretroviral treatment in WHO's goal of 3 by 5","volume":"366","author":"Daniels","year":"2005","journal-title":"Lancet"},{"key":"key-10.1136\/medethics-2016-103868-65","unstructured":"Bird SJ . Social Responsibility and Research Ethics: Not Either\/Or but Both. American Association for the Advancement of Science. 2014. https:\/\/www.aaas.org\/news\/social-responsibility-and-research-ethics-not-eitheror-both"},{"key":"key-10.1136\/medethics-2016-103868-66","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1080\/15265160802478412","article-title":"A broader view of justice","volume":"8","author":"Jecker","year":"2008","journal-title":"Am J Bioeth"},{"key":"key-10.1136\/medethics-2016-103868-67","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1093\/jmp\/jhs056","article-title":"The problem with rescue medicine","volume":"38","author":"Jecker","year":"2013","journal-title":"J Med Philos"},{"key":"key-10.1136\/medethics-2016-103868-68","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1080\/15265161.2014.990169","article-title":"Rethinking rescue medicine","volume":"15","author":"Jecker","year":"2015","journal-title":"Am J Bioeth"},{"key":"key-10.1136\/medethics-2016-103868-69","volume-title":"The Right and the Good","author":"Ross","year":"1930"},{"key":"key-10.1136\/medethics-2016-103868-70","volume-title":"Blindspot: hidden biases of good people","author":"Banaji","year":"2013"},{"key":"key-10.1136\/medethics-2016-103868-71","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/oso\/9780195113532.003.0010","article-title":"Implementing justice in a changing research environment","volume-title":"Beyond consent: seeking justice in research","author":"Kahn","year":"1998"}],"container-title":["Journal of Medical Ethics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/medethics-2016-103868","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T15:42:42Z","timestamp":1719157362000},"score":1,"resource":{"primary":{"URL":"https:\/\/jme.bmj.com\/lookup\/doi\/10.1136\/medethics-2016-103868"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,13]]},"references-count":71,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2017,5,26]]},"published-print":{"date-parts":[[2017,6]]}},"alternative-id":["10.1136\/medethics-2016-103868"],"URL":"https:\/\/doi.org\/10.1136\/medethics-2016-103868","relation":{},"ISSN":["0306-6800","1473-4257"],"issn-type":[{"value":"0306-6800","type":"print"},{"value":"1473-4257","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,13]]}}}